NSE lists at Rs 1,800 on BSE against Rs 1,785 issue price
The National Stock Exchange debuted on BSE at Rs 1,800 per share against its Rs 1,785 issue price, closing a Rs 22,562 crore offer for sale subscribed 5.71 times per exchange data.
The Development
The National Stock Exchange of India Limited (NSE) made its trading debut on 24 September 2026, its equity shares listing on BSE Limited at Rs 1,800 apiece against an issue price of Rs 1,785, a premium of about 0.8% at the open, per exchange data. Shares later touched an intraday high of Rs 1,878 on the BSE, roughly 5% above the issue price. The listing closes a Rs 22,562 crore offer, reported as the second-largest public issue in the Indian market.
The debut follows a three-day book-building window that ran from 17 to 21 September 2026, with anchor allocation completed on 16 September. Per the red herring prospectus filed with SEBI dated 10 September 2026, the offer was made entirely as an offer for sale of up to 126,436,650 equity shares of face value Re 1 each, so the company received no fresh capital. NSE shares list only on BSE, which the RHP names as the designated stock exchange for the offer, because an exchange does not list on its own platform.
The development was surfaced via coverage in The Economic Times, which reported the debut and the exchange's post-listing valuation.
The Company
NSE describes itself in the offer document as a vertically integrated, multi-asset-class exchange offering trading, clearing and listing on a single platform, alongside data feed, terminal and index licensing services. Per the RHP it operates across the cash market, equity and currency derivatives, commodity derivatives, the mutual funds platform, the wholesale debt market and interest rate futures. The company discloses it had 132.37 million unique registered investors and 3,005 listed entities as at 30 June 2026, with the market capitalisation of entities listed on it at Rs 474.08 trillion.
On financials, per the RHP the company reported revenue from operations of Rs 16,601.3 crore and profit for the year of Rs 10,302.1 crore in the financial year ended 31 March 2026, against Rs 17,140.7 crore and Rs 12,187.7 crore respectively in FY2025, a year in which both revenue and profit were higher. In FY2024 revenue from operations was Rs 14,780 crore and profit Rs 8,305.7 crore. The company discloses net worth of Rs 31,869.7 crore as at 31 March 2026 and nil borrowings. The offer document also states NSE does not have an identifiable promoter under the SEBI ICDR Regulations.
The Offer Structure
Per the RHP the offer was structured wholly as an offer for sale, meaning the proceeds, net of expenses, go to the selling shareholders rather than to NSE; the stated objects were to carry out the sale of up to 126,436,650 equity shares and to achieve the benefits of listing on BSE. The price band was set at Rs 1,700 to Rs 1,785 per share, with the issue priced at the Rs 1,785 cap. The named selling shareholders include State Bank of India (up to 15,969,410 shares), Canada Pension Plan Investment Board, Aranda Investments (Mauritius), MS Strategic (Mauritius), The New India Assurance Company and Bank of Baroda, among others.
The book was run by a large syndicate of book-running lead managers including Kotak Mahindra Capital, JM Financial, Morgan Stanley India, Citigroup Global Markets India, HSBC Securities, J.P. Morgan India and Axis Capital, with MUFG Intime India (formerly Link Intime) as registrar. Readers working through the arithmetic of an allotment can use Oquilia's lumpsum calculator or CAGR calculator; prior primary-market coverage sits on the Oquilia news desk.
Risk Factors
The RHP lists ten internal risk factors, several of which bear on the exchange's revenue model. The company discloses a trading-volume risk, noting that its revenue depends on trades executed on the exchange and that a significant decline in transaction volumes could materially affect its business. The RHP also flags a revenue-concentration risk: it derived 78.65% of revenue from operations from transaction charges in FY2026, largely from the options and futures businesses.
Among the other risks the company discloses are a trading-member concentration risk, its top ten trading members accounting for 46.78% of revenue from operations in FY2026, and a regulatory oversight risk, the RHP noting NSE operates in a highly regulated industry primarily overseen by SEBI and has received observations, show-cause notices and warning letters in certain matters. The document further lists enforcement and adjudication risk, cybersecurity risk (referencing a distributed denial-of-service attack it experienced in 2025) and clearing and settlement risk. These are the company's own required disclosures, not an external assessment.
What Happens Next
With listing complete, the primary-market process for this issue has run its course: the RHP, the price band and dates, the anchor book on 16 September, the 17 to 21 September subscription window, the basis of allotment and the unblocking of application funds have all concluded, and the shares now trade on BSE. Per exchange data the issue was subscribed 5.71 times overall, with qualified institutional buyers subscribing 12.68 times, non-institutional investors around six times and the retail category crossing its reserved portion; the company raised Rs 6,746 crore from nearly 189 anchor investors ahead of the opening.
From here, price discovery is a secondary-market matter driven by trading, and any future capital raising would require fresh disclosures. Applicants who received an allotment now hold shares that can be traded on BSE, while those whose applications were unsuccessful would have had their blocked funds released under the ASBA and UPI mechanism.
FAQ
Should I apply for this IPO?
Oquilia does not make recommendations. This report is informational and is not investment advice or a recommendation to subscribe. The bidding window for this offer has in any case closed and the shares are now listed on BSE. The RHP, including the complete risk-factors section, is available on SEBI's website and the exchanges; read it directly before making any decision.
What was the price band and issue price?
Per the RHP, the price band was Rs 1,700 to Rs 1,785 per equity share of face value Re 1, and the issue was priced at the Rs 1,785 cap. NSE listed on BSE at Rs 1,800 per share, a premium of about 0.8% to the issue price, per exchange data, and touched an intraday high of Rs 1,878.
Was this a fresh issue or an offer for sale?
It was entirely an offer for sale of up to 126,436,650 equity shares by existing shareholders, per the RHP. The company received no fresh proceeds; the money, net of expenses, goes to the selling shareholders. The stated objects were the sale itself and the benefits of listing on BSE.
How much was the issue subscribed?
Per exchange data the offer was subscribed 5.71 times overall, with qualified institutional buyers at 12.68 times, non-institutional investors around six times and the retail category crossing its reserved quota. The company raised Rs 6,746 crore from nearly 189 anchor investors ahead of the issue opening.
Where can I read the RHP?
The red herring prospectus is on SEBI's website under Filings, then Public Issues, and on the exchanges. It contains the full financials, the objects of the offer, the list of selling shareholders and the complete risk-factors section.
This report is based on the red herring prospectus filed with SEBI and on exchange subscription and listing data. It was surfaced via coverage in The Economic Times.